The alternative investment manager faces heightened scrutiny as analysts project a slowdown in revenue growth ahead of Tuesday's earnings release, despite a history of recent beats.
As Artisan Partners prepares to report fourth-quarter results, investors are weighing its recent track record against a backdrop of mixed signals from peers. Will this earnings release mark a turning point?
W.R. Berkley's Q4 earnings presented a mixed picture, meeting profit forecasts but missing on revenue. While management highlighted disciplined underwriting and tech-driven efficiency, analysts probed deeper into the challenges of competition, pricing, and strategic adaptation in a shifting market.
Chevron's fourth-quarter profit fell 12.5% year-over-year, pressured by lower oil prices, but the energy giant highlighted robust operational cash flow, record production levels following its Hess acquisition, and significant progress in its long-term strategic projects.
CONMED's latest earnings reveal a strategic pivot towards higher-growth surgical platforms, moving away from slower gastroenterology lines. While sales climbed, profitability softened, setting the stage for a crucial transition year as the market weighs the company's reset valuation against its ambitious 2026 roadmap.
Jacobs Solutions prepares to release its fourth-quarter financial results, with analysts projecting moderate revenue growth but watching closely after recent earnings misses and a volatile professional services landscape.
Emerson Electric Co. (NYSE: EMR) is scheduled to release its fiscal fourth-quarter earnings after Tuesday's market close, with investors watching for signs of sustained growth in industrial automation and software.
Veralto Corp. is set to report fourth-quarter earnings after Tuesday's market close, with investors watching for signs of sustained growth in water analytics and treatment demand. The report comes amid mixed signals from the broader environmental services sector.
Voya Financial is set to report fourth-quarter earnings after the bell Tuesday. Investors will watch to see if the financial services firm can maintain its impressive track record of surpassing revenue estimates, even as broader market headwinds pressure the custody banking sector.
American Financial Group (AFG) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with analysts anticipating flat revenue growth. The report comes as the property & casualty insurance sector faces headwinds from policy uncertainty and market volatility.
Prudential Financial (NYSE: PRU) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with investors closely watching for signs of resilience in the insurance sector.
As H&R Block prepares to report its fourth-quarter results, investors are weighing its consistent history of surpassing revenue estimates against a challenging discretionary spending environment and recent stock pressure.
As J&J Snack Foods prepares to release its quarterly results, investors are weighing stable analyst expectations against a backdrop of mixed performance in the shelf-stable food sector.
The research and advisory giant is expected to post modest revenue growth when it reports Tuesday morning, as investors weigh its performance against a mixed backdrop for IT services firms.
Alm. Brand A/S posts robust Q4 2025 results, with net income soaring to DKK 337 million and proposing a record dividend. While underlining its shareholder return strategy, the market grapples with valuation concerns and execution risks in a softening share price environment.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
High Tide Inc. reported record quarterly revenue and profitability in its fiscal Q4 2025, fueled by robust Canadian retail growth. The company outlined aggressive store expansion plans and detailed integration efforts for its new German medical cannabis asset, while also signaling cautious optimism regarding potential U.S. market entry.
Seaport Research has lowered its price target for Polaris Inc. (PII) following a strong fourth quarter overshadowed by softer-than-expected forward guidance. The firm maintains a Buy rating, citing the company's market share gains and operational improvements amidst ongoing tariff challenges.
Altria Group (MO) posted stronger-than-expected Q4 revenue, driven by its core tobacco brands and oral nicotine products, but saw its shares fall as profit margins contracted sharply. The company is betting on a national rollout of its ON! Plus pouches and manufacturing upgrades to fuel its smoke-free future.
Valley National Bancorp (VLY) reported fourth-quarter revenue and profit that topped Wall Street forecasts, driven by robust core deposit growth and disciplined balance sheet management. The regional bank's leadership pointed to strategic tech investments and commercial loan demand as key pillars for its 2025 outlook.
